Saint Gobain: the challenge of the new Canopée laboratory

( – The CNRS, the University of Lorraine and Saint-Gobain are meeting this Friday to sign the creation of a laboratory dedicated to the study of materials and ‘systems’ in extreme temperature conditions.

This structure, called ‘Canopée’ will pursue one objective: to reduce the carbon footprint of high temperature manufacturing processes.

Created for 5 years, Canopée has the ambition to build a better understanding of heat transfers, from the scale of the material to the scale of the industrial installation.

To meet this challenge, this laboratory ‘outside the walls’ will bring together experts in materials and thermal sciences, located in Orléans, Aubervilliers, Nancy and Cavaillon.


WORLDLINE / INGENICO: the offer is reopened from October 22 to November 4

(AOF) – Following the very large success of Worldline’s friendly public offer for Ingenico shares and OCEANEs, the offer is reopened from October 22 until November 4, 2020 (inclusive).

Worldline confirms its intention to implement a squeeze-out on Ingenico shares and OCEANEs following the reopening of the offer. In this regard, the payments specialist specifies that it is very likely that the conditions of the squeeze-out will already be met from the date of settlement-delivery of the initial offer.


The secrets of the indestructible beetle under the microscope

Scientists on Wednesday unveiled the secrets of the evil battleship scarab, impossible to crush even with a car, a discovery that could inspire engineering and robotics (AFP / Yuri KADOBNOV)

Indestructible: Scientists on Wednesday unveiled the secrets of the evil armored scarab, impossible to crush even with a car, a discovery that could inspire engineering and robotics.

With its rough black back, the “Nosoderma diabolicum” resembles a small boulder of about 2 cm, living mainly on the west coast of North America, under the bark of oak trees.

No longer having the ability of his ancestors to move away from predators by taking flight, he feigns death when attacked. But it also has a “remarkable ability to withstand crushing and puncturing blows from predators, and even from an automobile,” according to a study published in Nature.

The study proves that it can tolerate forces up to 39,000 times its weight: the creature could thus compete with cockroaches on the top of the podium of indestructible insects.

This ability, this beetle owes it to a pair of rigid front wings, the elytra, which function as an exoskeleton protecting the insect. They are so hard that entomologists bend their pins when they display the collections in display cases, the study reports.

Scientists from the United States and Japan have studied the structure of these elytra. Using advanced imaging techniques, they observed a series of jigsaw-shaped joints, fitting together like in a puzzle, and found that the shape of these blades and their layered microstructure worked to harden the armor.

Explanatory sheet of the evil armored scarab, impossible to crush even with a car.  (AFP /)

Explanatory sheet of the evil armored scarab, impossible to crush even with a car. (AFP /)

Although ultra-strong, this structure is flexible, giving the beetle the ability to hide under rocks, or twist under tree bark for shelter, carrying extra weight, without damaging its internal organs. .

The researchers then used 3D printing and simulations, to see if this geometric structure could be used as a mechanical fastener to join different materials – plastic and metal – similar to those required in the design of turbines in the aerospace industry. These designs have proven to be stronger than a common engineering joint. These beetles “could now inspire the design of compressible robots, as cockroaches which have the similar shape-changing ability, or armored vehicles have done.” , commented Po-Yu Chen, Department of Materials Science and Engineering at Tsing Hua University in Taiwan, in a comment on the sidelines of the study.

klm / toys / rh / ach


Technical malfunction halted Amsterdam stock exchange trading for hours | NOW

There was a malfunction on the Amsterdam stock exchange on Monday morning, reports Euronext, the company behind the stock exchange. A spokesperson says that the malfunction, which has now been resolved, had a technical cause.

The outage started around 10 a.m. and shut down trading on all Euronext exchanges until the early afternoon. In addition to Amsterdam, these are Brussels, Paris, London, Lisbon, Oslo and Dublin.

During the outage, trading was halted for all Euronext products. After noon, trading was resumed in phases after a pre-opening phase of 15 minutes.


Wall Street falls, pessimistic about the chances of new economic aid

A passerby in front of the New York Stock Exchange (NYSE) on Wall Street, New York, October 5, 2020 (AFP / Angela Weiss)

The New York Stock Exchange sank into the red Monday on the eve of a deadline set by the Democratic Speaker of the House of Representatives to reach a budget compromise on a new economic support plan for the United States.

Its flagship index, the Dow Jones Industrial Average, lost 1.44% to 28,195.42 points.

The Nasdaq, with strong technological coloring, dropped 1.65% to 11,478.88 points and the extended S&P 500 index fell 1.63% to 3,426.92 points.

These three major indices had started the session in the green before falling back.

Democratic Congresswoman Nancy Pelosi and Treasury Secretary Steven Mnuchin met on Monday to try to narrow their differences over the terms of a new aid plan for American businesses and households.

Ms Pelosi set a 48-hour deadline on Sunday to reach a compromise, but market participants appeared wary of any progress.

According to Sam Stovall of CFRA, Wall Street’s retreat on Monday is “a response to the declining possibilities for a stimulus plan to be voted on before the election (November presidential, editor’s note) and to the rise in concerns about the fact that there will also be no plan after the election. ”

Even if Democrat Joe Biden wins against Donald Trump on November 3, Republicans could retain their majority in the Senate, which would have the effect of “paralyzing Congress”, observes Mr. Stovall.

The results season also continued on Wall Street, where the American oil services group Halliburton (-0.68%), which has faced the decline in exploration and drilling activities since the start of the pandemic, recorded its fourth consecutive quarter of losses.

Netflix, Tesla or Coca-Cola will share their quarterly report this week.

Among the other stocks of the day, the American group ConocoPhillips (-3.17%) announced Monday its intention to buy its competitor Concho Resources (-2.76%), specializing in the exploitation of shale oil, for 9, $ 7 billion, a new sign of consolidation in a sector shaken by the pandemic.

American Airlines (+ 0.80%) rose after announcing its intention to put the 737 MAX back into service at the end of the year, Boeing’s flagship aircraft which is still awaiting the green light from the authorities to fly back after two accidents with kills 346.

Market players also digested China’s third-quarter GDP figures, which jumped 4.9%, according to figures released Monday by the National Bureau of Statistics (SNB), marking a boost as the Most of the major economies were weighed down by the Covid-19 pandemic.

However, this increase is lower than the forecasts of a group of analysts polled by AFP, who expected an increase of 5.2%.


dho / lo / esp


Keolis and NAVYA launch their first fully autonomous shuttle

(AOF) – Keolis and Navya, partners in autonomous mobility since 2016, are launching their first fully autonomous shuttle service within the National Sports Shooting Center (CNTS) in Châteauroux. This service, intended to ensure the movement of athletes and visitors in the center, in particular on the occasion of upcoming competitions, is developed in partnership with Châteauroux Métropole and the French Shooting Federation.

“This entry into service is a decisive step in the development of a multimodal offer integrating fully autonomous level 4 vehicles”, explained the two companies.



DRONE VOLT: success of a bond issue of 1.132 million euros

(AOF) – Drone Volt announced the success of a bond issue of 1.132 million euros. The group decided to proceed with a new issue with the same characteristics as the two previous issues, with maturities in 2022, which had become too small and which were repaid at the end of September 2020 in cash. This issue is similar to a classic loan over 3 years with a monthly repayment of interest (7% per year) and capital in cash.

At maturity, the subscriber will receive additional interest at the end of 7% per annum.

The drone specialist enjoys a repayment option at any time without penalty, as well as an option to repay the principal and remaining interest owed in shares.

The loan maturities are therefore intended to be repaid in cash, making it possible to limit dilution. Drone Volt retains however the possibility of repaying the capital and interest in shares.

Using the closing price of October 15, 2020, the maximum dilution of this issue would be 2.6%. Thus, a shareholder who would hold 1% of the capital before the transaction would thus hold 0.974% in the event of repayment made entirely in shares.



AXA: relapse heavily on contact with 15.1E

( – AXA opens a ‘gap’ under 15.75E and relapses heavily on contact with 15.1E, pulverizing the support of 15.6E (from 25/09 to 02/10) and threatening that of 15.15E May 14/15.

The next support is now emerging around 13.95E, the good support of April 3 (strong reactivity to the rise of the title)


Airbus: analysts’ opinions after the order book

( – Airbus announced that it had delivered 57 commercial aircraft in September 2020, up from 71 a year earlier. The aircraft manufacturer also presents the sales figures for the past months: 14 deliveries in April, 24 in May, 36 in June, 49 in July and 39 in August. The Airbus order book stands at 7,441 aircraft compared to 7,133 at the same time last year.

Since the start of the year, Airbus has delivered a total of 341 aircraft (18 A220s, 282 of the A320 Family, 9 A330s and 32 A350s), a decrease of around 40% compared to the same period per year. passed (571 deliveries).

In contrast, in the first three quarters of 2020, Airbus recorded a total of 300 commercial aircraft orders compared to 127 orders in the same period last year.

Oddo anticipates a sharp acceleration in profitability in the third quarter with adjusted EBIT of 930 million euros (-42%) and sales of 11.6 billion euros (-24%).

The analyst thus models a clear return in order volumes for the commercial branch with 145 deliveries in the 3rd quarter against 74 in the 2nd quarter.

The analyst reiterates his recommendation to buy with a price target of 89 euros. ‘The in-depth analysis of the delivery skyline that we carried out in our last note shows that the current pace offers a solid floor,’ says Oddo.

Barclays reaffirms for its part its recommendation to ‘overweight’ on Airbus, but with a price target reduced to 68 euros, in the wake of its forecasts closer to the publication of third quarter results on October 29.

“We expect most investors to focus their attention on the cash outlook,” said the broker, recalling that “the current ambition is to avoid cash consumption before M&A and client financing in the second half”.

Barclays believe that target will be reaffirmed, but he believes investors are likely to remain concerned about the aircraft maker’s ability to generate cash next year.

Berenberg announced that he had raised to ‘keep’ to ‘buy’ his recommendation on Airbus, believing that the existence of an opportunity on the value had now become evident. The intermediary raised its price target on the title from 69 to 76 euros, which shows a potential increase of 22% compared to current levels of the action.

BofA – which maintains its recommendation to buy the title – takes the opportunity to raise its price target from 84 to 86 euros.


SANOFI: encouraging results from a vaccine against Covid-19

(AOF) – Sanofi and Translate Bio have announced the preclinical results of MRT5500, an mRNA vaccine candidate against SARS-CoV-2, the virus responsible for Covid-19. The preclinical evaluation of MRT5500 in particular showed a favorable immune response profile against SARS-CoV-2. These data justify the continued clinical development of this vaccine candidate and the conduct of a phase I / II clinical trial which should begin in the fourth quarter of 2020.